Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
OPCH 
Option Care Health Inc (OPCH)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/02/2025: OPCH (2-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Number of Analysts
10 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $35.3
1 Year Target Price $35.3
| 6 | Strong Buy |
| 3 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 1.35% | Avg. Invested days 44 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 12/02/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 4.98B USD | Price to earnings Ratio 24.34 | 1Y Target Price 35.3 |
Price to earnings Ratio 24.34 | 1Y Target Price 35.3 | ||
Volume (30-day avg) 10 | Beta 0.81 | 52 Weeks Range 22.29 - 35.53 | Updated Date 12/2/2025 |
52 Weeks Range 22.29 - 35.53 | Updated Date 12/2/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 1.26 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 3.78% | Operating Margin (TTM) 5.89% |
Management Effectiveness
Return on Assets (TTM) 6.03% | Return on Equity (TTM) 15.03% |
Valuation
Trailing PE 24.34 | Forward PE 18.12 | Enterprise Value 5882334904 | Price to Sales(TTM) 0.9 |
Enterprise Value 5882334904 | Price to Sales(TTM) 0.9 | ||
Enterprise Value to Revenue 1.06 | Enterprise Value to EBITDA 14.6 | Shares Outstanding 158732706 | Shares Floating 149254776 |
Shares Outstanding 158732706 | Shares Floating 149254776 | ||
Percent Insiders 0.81 | Percent Institutions 107.25 |
Upturn AI SWOT
Option Care Health Inc
Company Overview
History and Background
Option Care Health, Inc. (OCRX) was founded in 1979 as a division of Baxter International and later spun off. It became a leading independent provider of home and alternate site infusion services. Significant milestones include acquisitions and expansions to broaden its service offerings and geographic reach.
Core Business Areas
- Infusion Therapy Services: Provides a range of infusion therapies for various acute and chronic conditions, including anti-infectives, nutrition support, and immunoglobulin therapy.
- Specialty Pharmacy Services: Offers access to specialty medications, clinical expertise, and patient education to support complex therapies.
Leadership and Structure
John C. Rademacher is the President and CEO. The company has a structured organizational framework with key functional departments such as operations, clinical services, sales, and finance.
Top Products and Market Share
Key Offerings
- Anti-Infective Infusion Therapy: Provides IV antibiotics for infections. Competitors include CVS Health (CVS), Walgreens Boots Alliance (WBA), and OptumRx. Market share difficult to isolate for this specific offering but falls under overall home infusion therapy market.
- Nutrition Support Infusion Therapy: Provides parenteral nutrition for patients unable to receive adequate nutrition orally. Competitors include CVS Health (CVS), Walgreens Boots Alliance (WBA), and OptumRx. Market share difficult to isolate for this specific offering but falls under overall home infusion therapy market.
- Immunoglobulin (Ig) Infusion Therapy: Provides intravenous or subcutaneous Ig therapy for immune deficiencies. Competitors include CVS Health (CVS), Walgreens Boots Alliance (WBA), and OptumRx. Market share difficult to isolate for this specific offering but falls under overall home infusion therapy market.
Market Dynamics
Industry Overview
The home and alternate site infusion market is growing due to increasing healthcare costs, an aging population, and advancements in infusion therapies. There's also a shift towards delivering care in more convenient and cost-effective settings.
Positioning
Option Care Health is a leading independent provider with a strong focus on clinical expertise and patient care. It differentiates itself through its comprehensive service offerings and national footprint.
Total Addressable Market (TAM)
The US home infusion therapy market is expected to reach around $25 billion by 2027. Option Care Health is well-positioned to capture a significant share of this growing market due to its national presence, established infrastructure, and clinical expertise.
Upturn SWOT Analysis
Strengths
- National footprint
- Strong clinical expertise
- Comprehensive service offerings
- Established relationships with payers
- Focus on patient care
Weaknesses
- Highly regulated industry
- Reimbursement pressures
- Competition from large pharmacy chains
- Dependence on key suppliers
- Potential for errors in care
Opportunities
- Expanding into new geographic markets
- Developing new infusion therapies
- Acquiring smaller competitors
- Partnering with healthcare providers
- Leveraging technology to improve efficiency
Threats
- Changes in reimbursement policies
- Increased competition
- Economic downturn
- Cybersecurity threats
- Product liability claims
Competitors and Market Share
Key Competitors
- CVS (CVS)
- WBA (Walgreens Boots Alliance)
- UnitedHealth Group (UNH) OptumRx
Competitive Landscape
Option Care Health faces competition from large pharmacy chains and other home infusion providers. It differentiates itself through its clinical expertise, comprehensive service offerings, and national footprint. However, the larger players have significant scale advantages.
Major Acquisitions
BioMatrix Specialty Pharmacy
- Year: 2021
- Acquisition Price (USD millions): 130
- Strategic Rationale: Expanded Option Care Health's specialty pharmacy capabilities and patient access, as well as geographic reach.
Growth Trajectory and Initiatives
Historical Growth: Option Care Health has experienced strong growth in recent years, driven by organic growth and acquisitions.
Future Projections: Analysts project continued growth for Option Care Health, driven by the aging population, increasing prevalence of chronic diseases, and shift towards home-based care.
Recent Initiatives: Recent initiatives include expanding into new geographic markets, developing new infusion therapies, and investing in technology to improve efficiency.
Summary
Option Care Health is a leading provider in the growing home and alternate site infusion market. Its strong clinical expertise, national footprint, and focus on patient care are significant advantages. However, reimbursement pressures and competition from larger pharmacy chains pose challenges. Continued innovation and strategic acquisitions will be key to sustaining growth.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company filings
- Industry reports
- Analyst estimates
- Company Website
Disclaimers:
The data provided is for informational purposes only and should not be considered investment advice. Market share data is based on estimates and may vary.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Option Care Health Inc
Exchange NASDAQ | Headquaters Bannockburn, IL, United States | ||
IPO Launch date 1996-08-15 | CEO, President & Director Mr. John C. Rademacher | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 8000 | Website https://www.optioncarehealth.com |
Full time employees 8000 | Website https://www.optioncarehealth.com | ||
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as Duchenne muscular dystrophy, multiple sclerosis, Alzheimer's disease, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.